NIH专家建议用DASH饮食控制血压,比吃药好

2018-01-06 Shirley 全球医生组织

美国国立卫生研究院(NIH)研发的DASH饮食连续八年被“美国新闻与世界报道”评为“最佳饮食”。最新研究表明,将DASH饮食与低钠饮食相结合明显降低血压,起到控制血压的作用,甚至比降压药更好。

美国国立卫生研究院(NIH)研发的DASH饮食连续八年被“美国新闻与世界报道”评为“最佳饮食”。最新研究表明,将DASH饮食与低钠饮食相结合明显降低血压,起到控制血压的作用,甚至比降压药更好。

NIH-DASH餐食最科学的配比


什么是DASH饮食?

DASH饮食是NIH附属心肺血液研究所(NHLBI)研发的一种大众健康新型饮食,以丰富的水果、蔬菜、低脂乳制品和瘦肉蛋白为重点,还包括五谷杂粮、瘦肉、鱼肉和家禽肉、坚果和豆类等,具有纤维含量高,脂肪含量低等特质。可通过此膳食方法预防和控制高血压

据世界卫生组织数据统计,高血压是全球最常见慢病之一,也是导致心脏病的主要风险因素。全球每年约有10亿人患高血压,且死亡人数中约八分之一的人死于高血压病。

NIH研究人员通过研究证实了DASH饮食能有效预防和控制高血压。此外,还有降低胆固醇、减肥功效。在“健康饮食”和“心脏病预防”排名中第一。

NHLBI注册营养师耶斯表示:“多年来DASH的高排名显示了人们对该饮食的认可度和采用度越来越高,不仅仅是健康管理专家,也有广大民众。令人欣慰的是,最新研究证实:少钠餐与DASH饮食相结合,有明显降低血压作用。”

已往研究表明,遵循DASH饮食的人可以在短短两周内将血压降低几个百分点。随着时间推移,高血压患者的收缩压会下降8—14个百分点,因此,降低了心血管疾病风险。

DASH与低钠饮食结合,对健康积极意义更大

近期,NHLBI研究人员对400多位高血压前期或1期成年人进行了临床试验,结果发现,低盐饮食与DASH相结合显着降低了受试者的收缩压。令人印欣慰的是血压越高的患者降低幅度最大。

约翰霍普金斯大学专家也证实了该项观察结果:严格遵循DASH饮食的高血压患者与服用抗高血压药物的患者降压效果相当。这个结果表明了DASH饮食对患有高血压病的患者有着积极有效的作用,或比服用降压药更有效。

因此,专家建议DASH饮食计划应作为每个人健康饮食的参考。人人都可以享受DASH饮食,有如此多益处,你还等什么?或许不久将来,DASH饮食将成为高血压人群第一治疗选择。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2042088, encodeId=fe9d2042088f1, content=<a href='/topic/show?id=74685e1614' target=_blank style='color:#2F92EE;'>#DASH饮食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5716, encryptionId=74685e1614, topicName=DASH饮食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Nov 19 02:38:00 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988332, encodeId=fced1988332a0, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Tue Jul 24 20:38:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784097, encodeId=05a81e84097ea, content=<a href='/topic/show?id=82d25e154b' target=_blank style='color:#2F92EE;'>#DASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5715, encryptionId=82d25e154b, topicName=DASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Mon Mar 26 21:38:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301234, encodeId=aeb413012347c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536917, encodeId=f6ac153691e9c, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276010, encodeId=2d1c2e6010e4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Sat Jan 06 12:54:51 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2042088, encodeId=fe9d2042088f1, content=<a href='/topic/show?id=74685e1614' target=_blank style='color:#2F92EE;'>#DASH饮食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5716, encryptionId=74685e1614, topicName=DASH饮食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Nov 19 02:38:00 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988332, encodeId=fced1988332a0, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Tue Jul 24 20:38:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784097, encodeId=05a81e84097ea, content=<a href='/topic/show?id=82d25e154b' target=_blank style='color:#2F92EE;'>#DASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5715, encryptionId=82d25e154b, topicName=DASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Mon Mar 26 21:38:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301234, encodeId=aeb413012347c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536917, encodeId=f6ac153691e9c, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276010, encodeId=2d1c2e6010e4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Sat Jan 06 12:54:51 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2042088, encodeId=fe9d2042088f1, content=<a href='/topic/show?id=74685e1614' target=_blank style='color:#2F92EE;'>#DASH饮食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5716, encryptionId=74685e1614, topicName=DASH饮食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Nov 19 02:38:00 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988332, encodeId=fced1988332a0, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Tue Jul 24 20:38:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784097, encodeId=05a81e84097ea, content=<a href='/topic/show?id=82d25e154b' target=_blank style='color:#2F92EE;'>#DASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5715, encryptionId=82d25e154b, topicName=DASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Mon Mar 26 21:38:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301234, encodeId=aeb413012347c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536917, encodeId=f6ac153691e9c, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276010, encodeId=2d1c2e6010e4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Sat Jan 06 12:54:51 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-03-26 tm10051981
  4. [GetPortalCommentsPageByObjectIdResponse(id=2042088, encodeId=fe9d2042088f1, content=<a href='/topic/show?id=74685e1614' target=_blank style='color:#2F92EE;'>#DASH饮食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5716, encryptionId=74685e1614, topicName=DASH饮食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Nov 19 02:38:00 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988332, encodeId=fced1988332a0, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Tue Jul 24 20:38:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784097, encodeId=05a81e84097ea, content=<a href='/topic/show?id=82d25e154b' target=_blank style='color:#2F92EE;'>#DASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5715, encryptionId=82d25e154b, topicName=DASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Mon Mar 26 21:38:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301234, encodeId=aeb413012347c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536917, encodeId=f6ac153691e9c, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276010, encodeId=2d1c2e6010e4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Sat Jan 06 12:54:51 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-01-07 kksonne
  5. [GetPortalCommentsPageByObjectIdResponse(id=2042088, encodeId=fe9d2042088f1, content=<a href='/topic/show?id=74685e1614' target=_blank style='color:#2F92EE;'>#DASH饮食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5716, encryptionId=74685e1614, topicName=DASH饮食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Nov 19 02:38:00 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988332, encodeId=fced1988332a0, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Tue Jul 24 20:38:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784097, encodeId=05a81e84097ea, content=<a href='/topic/show?id=82d25e154b' target=_blank style='color:#2F92EE;'>#DASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5715, encryptionId=82d25e154b, topicName=DASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Mon Mar 26 21:38:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301234, encodeId=aeb413012347c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536917, encodeId=f6ac153691e9c, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276010, encodeId=2d1c2e6010e4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Sat Jan 06 12:54:51 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-01-07 宋威
  6. [GetPortalCommentsPageByObjectIdResponse(id=2042088, encodeId=fe9d2042088f1, content=<a href='/topic/show?id=74685e1614' target=_blank style='color:#2F92EE;'>#DASH饮食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5716, encryptionId=74685e1614, topicName=DASH饮食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Nov 19 02:38:00 CST 2018, time=2018-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988332, encodeId=fced1988332a0, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Tue Jul 24 20:38:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784097, encodeId=05a81e84097ea, content=<a href='/topic/show?id=82d25e154b' target=_blank style='color:#2F92EE;'>#DASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5715, encryptionId=82d25e154b, topicName=DASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Mon Mar 26 21:38:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301234, encodeId=aeb413012347c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536917, encodeId=f6ac153691e9c, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sun Jan 07 23:38:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276010, encodeId=2d1c2e6010e4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Sat Jan 06 12:54:51 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-01-06 祝您健康

    学习

    0

相关资讯

2016 基金委与NIH生物医学合作项目初审结果发布

x"> 复旦大学 107 8161101337 岛叶相关神经环路在精神疾病共病发病机制的基因影像学研究 汪凯 安徽医科大学

NIH院长:基因筛查发现致病突变毫无意义

DNA基因筛查结果可以预测某些疾病,特别是与基因突变密切相关的遗传病发病几率。但是,这既不是临床诊断也不能预知何时发病。

美尼曼匹克氏症临床试验一关键挫折遭忽视

美尼曼匹克氏症临床试验一关键挫折遭忽视  美国国立卫生研究员临床中心是一项NPC临床试验的所在地。不过,当并发症出现时,该试验被叫停。 图片来源:美国国立卫生研究院 当美国国立卫生研究院(NIH)院长Francis Collins于5年前提出在NIH成立一个新的转化医学中心时,他遭到了足够多的质疑。默克公司前首席执行官Roy Vagelos告诉一个国会委员会

美国国立卫生研究院采用新算法评估论文影响力

图片来源:yahoo.com 在全球最大的生物医学资助机构——美国国立卫生研究院(NIH),一种鲜为人知的对研究论文影响力进行评分的算法已成为重要的基金管理工具。 2015年,NIH投资组合分析办公室(OPA)设计了该工具,旨在更加公平地比较来自不同领域的论文的表现。如今,NIH最大的机构之一正在利用相对引用率(RCR)这一标准,确认某些类型的基金获得的收益是否

美国立卫生研究院发布首份全机构战略规划

图片来源:美国国立卫生研究院 近日,美国国立卫生研究院(NIH)发布20多年来的首份全机构战略规划。虽然这份文件在很大程度上是对该机构正在做的事情的综述,但它让一些NIH顾问怀疑规划是否承诺了太多。 尽管一些NIH顾问持保留意见,但一位呼吁制定此项规划的立法者认为,它正是国会想看见的内容。在一份声明中,众议员Andy Harris称这份战略规划“具有开创性”,并且“朝着在NIH

听Felipe Sierra博士谈衰老生物学

2017年11月6-10日由冷泉港亚洲举办的Stem Cells, Aging &Rejuvenation学术会议在苏州举办。美国NIH 衰老研究所(National Institute on Aging)衰老生物学主任的Felipe Sierra博士作为嘉宾在会议上做了主题演讲,并在会后接受了我们的采访。